A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Recruiting
500 enrolled
JPMS-DTC
Active not recruiting
453 enrolled
PREDAPT-HNSCC2
Withdrawn
DP-04
Recruiting
100 enrolled
CAMPERR
Recruiting
7,000 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
Completed
135 enrolled
ELEPHAS-02
Recruiting
416 enrolled
NEUTROFLOW
Not yet recruiting
600 enrolled
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
Active not recruiting
1,150 enrolled
SYMTECH01
Completed
33 enrolled
TraveraRTGx
Recruiting
200 enrolled
Real-world Study of First Line Pembrolizumab- or Nivolumab-treated HPV-positive Recurrent/Metastatic Oropharyngeal Squamous Cell Carcinoma
Completed
662 enrolled
ORACLE
Recruiting
2,020 enrolled
PREMIER
Recruiting
500 enrolled
DESCENT-1
Enrolling by invitation
400 enrolled
ProNiHN
Completed
502 enrolled
Observational Study of Nivolumab in Participants in Germany With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based Therapy
Completed
485 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Completed
1,149 enrolled
PREFER
Completed
1,429 enrolled
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Recruiting
475 enrolled
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Withdrawn
Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment
Recruiting
500 enrolled
Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTEâ¢
Recruiting
180 enrolled
QUANTUM
Enrolling by invitation
3,000 enrolled
ETCETERA
Not yet recruiting
80 enrolled
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Recruiting
20,000 enrolled
Real-World Evidence and Treatment Patterns: Head and Neck Cancer
Completed
43,994 enrolled
A Study to Assess Safety of Nivolumab in Routine Oncology Practice in China
Completed
3,102 enrolled
Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma
Recruiting
380 enrolled
RIFTOS MKI
Completed
667 enrolled
Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences
Not yet recruiting
500 enrolled
Discovering Factors in Head and Neck Cancer Patients' Clinical Study Experiences
Not yet recruiting
500 enrolled
Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients
Unknown
1,000 enrolled
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Unknown
3,000 enrolled
This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
Terminated
22 enrolled
DETECT
Completed
458 enrolled
VOLUME-PRO
Completed
509 enrolled
Effectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has Spread
Completed
262 enrolled
A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe
Completed
304 enrolled
Verification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity Cancer
Completed
1,160 enrolled
NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules
Unknown
400 enrolled
Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
Completed
893 enrolled
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
Unknown
279 enrolled
PIONEER
Unknown
1,000 enrolled
Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy
Terminated
8 enrolled
Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)
Completed
629 enrolled
Study to Evaluate the Safety of Nanoxel M Inj.
Unknown
1,498 enrolled
Developing an In-vitro Diagnostic Risk-Stratification Test for Oral Cancer
Unknown
370 enrolled